Advanced search
Publication Cover
OncoTargets and Therapy Volume 13, 2020 - Issue
Submit an article Journal homepage
74
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Erdheim–Chester Disease and Acute Myeloid Leukemia with Mutated NPM1 in a Patient with Clonal Hematopoiesis: A Case Report

Sotirios G Papageorgiou1 2nd Department of Internal Medicine and Research Unit, Hematology Unit, University General Hospital “Attikon”, Haidari, Athens, GreeceCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3376-837X
ORCID Icon,
Aspasia Divane2 “LIFE CODE” Private Diagnostic Laboratory, Medical Ltd., Athens, Greece
,
Maria Roumelioti3 1st Department of Propaedeutic Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece
,
Christine Kottaridi4 2nd Department of Pathology, National and Kapodistrian University of Athens, Medical School, University General Hospital “Attikon”, Haidari, Athens, Greece
,
Anthi Bouchla1 2nd Department of Internal Medicine and Research Unit, Hematology Unit, University General Hospital “Attikon”, Haidari, Athens, Greece
,
Alexandros Georgakopoulos5 2nd Department of Radiology, Nuclear Medicine Section, National and Kapodistrian University of Athens, University General Hospital “Attikon”, Haidari, Athens, Greece
,
Fotini Ieremiadou2 “LIFE CODE” Private Diagnostic Laboratory, Medical Ltd., Athens, Greece
,
Aggeliki Daraki2 “LIFE CODE” Private Diagnostic Laboratory, Medical Ltd., Athens, Greece
,
Efthymia Bazani1 2nd Department of Internal Medicine and Research Unit, Hematology Unit, University General Hospital “Attikon”, Haidari, Athens, Greece
,
Thomas P Thomopoulos1 2nd Department of Internal Medicine and Research Unit, Hematology Unit, University General Hospital “Attikon”, Haidari, Athens, Greece
,
Sofia Chatziioannou5 2nd Department of Radiology, Nuclear Medicine Section, National and Kapodistrian University of Athens, University General Hospital “Attikon”, Haidari, Athens, Greece;6 Nuclear Medicine Section, Biomedical Research Foundation Academy of Athens, BRFAA, Athens, Greece
,
Andreas Mavrogenis7 1st Department of Orthopaedics, National and Kapodistrian University of Athens, School of Medicine, University General Hospital “Attikon”, Haidari, Athens, GreeceORCID Iconhttps://orcid.org/0000-0003-0807-0719
ORCID Icon,
Panayiotis Panayiotidis3 1st Department of Propaedeutic Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece
,
Ioannis G Panayiotides4 2nd Department of Pathology, National and Kapodistrian University of Athens, Medical School, University General Hospital “Attikon”, Haidari, Athens, Greece
,
Vasiliki Pappa1 2nd Department of Internal Medicine and Research Unit, Hematology Unit, University General Hospital “Attikon”, Haidari, Athens, Greece
&
Periklis G Foukas4 2nd Department of Pathology, National and Kapodistrian University of Athens, Medical School, University General Hospital “Attikon”, Haidari, Athens, Greece
 show all
Pages 11689-11695 | Published online: 16 Nov 2020

References

  • Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390. doi:10.1182/blood-2016-01-64356926980727
  • Diamond EL, Dagna L, Hyman DM, et al. Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease. Blood. 2014;124:483–492. doi:10.1182/blood-2014-03-56138124850756
  • Mavrogenis AF, Igoumenou VG, Antoniadou T, et al. Rare diseases of bone: Erdheim-Chester and Rosai-Dorfman non-Langerhans cell histiocytosis. EFORT Open Rev. 2018;3:381–390. doi:10.1302/2058-5241.3.17004730034819
  • Goyal G, Heaney ML, Collin M, et al. Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood. 2020;135:1929–1945.32187362
  • Emile JF, Abla O, Fraitag S, et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127:2672–2681. doi:10.1182/blood-2016-01-69063626966089
  • Berres ML, Lim KP, Peters T, et al. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. J Exp Med. 2014;211:669–683. doi:10.1084/jem.2013097724638167
  • Haroche J, Cohen-Aubart F, Charlotte F, et al. The histiocytosis Erdheim-Chester disease is an inflammatory myeloid neoplasm. Expert Rev Clin Immunol. 2015;11:1033–1042. doi:10.1586/1744666X.2015.106085726197238
  • Milne P, Bigley V, Bacon CM, et al. Hematopoietic origin of langerhans cell histiocytosis and Erdheim-Chester disease in adults. Blood. 2017;130:167–175. doi:10.1182/blood-2016-12-75782328512190
  • Durham BH, Roos-Weil D, Baillou C, et al. Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells. Blood. 2017;130:176–180. doi:10.1182/blood-2016-12-75737728566492
  • Bonnet P, Chasset F, Moguelet P, et al. Erdheim-Chester disease associated with chronic myelomonocytic leukemia harboring the same clonal mutation. Haematologica. 2019;104(11):e530–e533. doi:10.3324/haematol.2019.22355231221777
  • Ghobadi A, Miller CA, Li T, et al. Shared cell of origin in a patient with Erdheim-Chester disease and acute myeloid leukemia. Haematologica. 2019;104:e373–e375. doi:10.3324/haematol.2019.21779430923101
  • Papo M, Diamond EL, Cohen-Aubart F, et al. High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis. Blood. 2017;130:1007–1013.28679734
  • Capo-Chichi J-M, Michaels P, Tremblay-Le R, Abelson S, Hasserjian RP, Xia D. Emerging patterns in clonal haematopoiesis. J Clin Pathol. 2019;72:453–459. doi:10.1136/jclinpath-2019-20585131164443
  • Haroche J, Cohen-Aubart F, Amoura Z. Erdheim-Chester disease. Blood. 2020;135(16):1311–1318. doi:10.1182/blood.201900276632107533
  • Wang JN, Qiu Y, Niu N, et al. Successful treatment of central nervous system involved Erdheim-Chester disease by intermediate-dose cytarabine as first-line therapy. Acta Oncol. 2020;59:302–305. doi:10.1080/0284186X.2019.167035531559889
  • Tvedt TH, Nepstad I, Bruserud Ø. Antileukemic effects of midostaurin in acute myeloid leukemia – the possible importance of multikinase inhibition in leukemic as well as nonleukemic stromal cells. Expert Opin Investig Drugs. 2017;26(3):343–355. doi:10.1080/13543784.2017.1275564
  • Roeser A, Bravetti M, Azoulay L-D, et al. High serum VEGF level in erdheim-chester disease: correlation with cardiovascular involvement and response to treatment. Blood. 2019;134(Supplement_1):2324. doi:10.1182/blood-2019-129984
  • Takahashi K, Wang F, Kantarjian H, et al. Copy number alterations detected as clonal hematopoiesis of indeterminate potential. Blood Adv. 2017;1:1031–1103. doi:10.1182/bloodadvances.201700792229296745

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.